Agomab Spain S.L.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants (NCT06397508) | Agomab Spain S.L. | 2024-04-02 |
| Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF (NCT06181370) | Agomab Spain S.L. | 2023-12-01 |
| Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants (NCT05937386) | Agomab Spain S.L. | 2023-08-09 |
Track Agomab Spain S.L. automatically
Every clearance here is in the API, with alerts when new ones post.